Innovation & intellectual property · 20/07/2017Updated: 10/17/2026 · 1 min read
USPTO Grants Interim Extension for Benralizumab Patent
Summary
The US Patent and Trademark Office has issued an order granting a one-year interim extension for the term of U.S. Patent No. 7,179,464, which covers the life-saving medication benralizumab.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →